Salicylaldoxime - CAS 94-67-7
Catalog: |
BB041454 |
Product Name: |
Salicylaldoxime |
CAS: |
94-67-7 |
Synonyms: |
2-(hydroxyiminomethyl)phenol |
IUPAC Name: | 2-[(E)-hydroxyiminomethyl]phenol |
Description: | Salicylaldoxime (CAS# 94-67-7) is an intermediate in the synthesis of Acifluorfen-methyl-2-amino (A189975), a derivative of Acifluorfen (A795248), a herbicide. |
Molecular Weight: | 137.14 |
Molecular Formula: | C7H7NO2 |
Canonical SMILES: | C1=CC=C(C(=C1)C=NO)O |
InChI: | InChI=1S/C7H7NO2/c9-7-4-2-1-3-6(7)5-8-10/h1-5,9-10H |
InChI Key: | ORIHZIZPTZTNCU-UHFFFAOYSA-N |
Density: | 1.42 g/cm3 |
Appearance: | Solid |
Storage: | Sealed in dry, Room Temperature |
LogP: | 1.20030 |
GHS Hazard Statement: | H302 (95.56%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021117053-A1 | An improved process for preparation of pure aldoxime | 20191212 |
US-2021095077-A1 | Process for manufacturing a cross-linked product | 20190930 |
US-2021047294-A1 | Imidazolyl pyrimidinylamine compounds as cdk2 inhibitors | 20190814 |
WO-2021030537-A1 | Imidazolyl pyrimidinylamine compounds as cdk2 inhibitors | 20190814 |
WO-2020254490-A1 | Phenoxyphenyl hydroxyisoxazolines and analogues as new antifungal agents | 20190621 |
PMID | Publication Date | Title | Journal |
22930397 | 20121128 | Synthesis, crystal structure and magnetism of new salicylamidoxime-based hexanuclear manganese(III) single-molecule magnets | Dalton transactions (Cambridge, England : 2003) |
22488421 | 20120807 | Linking [M(III)3] triangles with 'double-headed' phenolic oximes | Dalton transactions (Cambridge, England : 2003) |
22817932 | 20120715 | Improvement of copper FAAS determination conditions via preconcentration procedure with the use of salicylaldoxime complex trapped in polymer matrix | Talanta |
22512906 | 20120515 | Synthesis, biological evaluation, and molecular docking studies of 2,6-dinitro-4-(trifluoromethyl)phenoxysalicylaldoxime derivatives as novel antitubulin agents | Bioorganic & medicinal chemistry |
21481497 | 20110601 | Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes | European journal of medicinal chemistry |
Complexity: | 125 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 137.047678466 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 137.047678466 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 52.8 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 1 |
XLogP3: | 1.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Nitrogen Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS